Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Feb;14(2):88-101.
doi: 10.1038/nrcardio.2016.173. Epub 2016 Nov 10.

Diagnosis, pathophysiology, and management of exercise-induced arrhythmias

Affiliations
Free article
Review

Diagnosis, pathophysiology, and management of exercise-induced arrhythmias

Eduard Guasch et al. Nat Rev Cardiol. 2017 Feb.
Free article

Abstract

The cardiovascular benefits of physical activity are indisputable. Nevertheless, growing evidence suggests that both atrial fibrillation and right ventricular arrhythmia can be caused by intense exercise in some individuals. Exercise-induced atrial fibrillation is most commonly diagnosed in middle-aged, otherwise healthy men who have been engaged in endurance training for >10 years, and is mediated by atrial dilatation, parasympathetic enhancement, and possibly atrial fibrosis. Cardiac ablation is evolving as a first-line tool for athletes with exercise-induced arrhythmia who are eager to remain active. The relationship between physical activity and right ventricular arrhythmia is complex and involves genetic and physical factors that, in a few athletes, eventually lead to right ventricular dilatation, followed by subsequent myocardial fibrosis and lethal ventricular arrhythmias. Sinus bradycardia and atrioventricular conduction blocks are common in athletes, most of whom remain asymptomatic, although incomplete reversibility has been shown after exercise cessation. In this Review, we summarize the evidence supporting the existence of exercise-induced arrhythmias and discuss the specific considerations for the clinical management of these patients.

PubMed Disclaimer

References

    1. Circulation. 2016 Feb 2;133(5):466-73 - PubMed
    1. Circulation. 2016 May 17;133(20):1927-35 - PubMed
    1. Circulation. 2009 Feb 10;119(5):e195; author reply e196 - PubMed
    1. Europace. 2011 Oct;13(10):1386-93 - PubMed
    1. Europace. 2013 Aug;15(8):1070-118 - PubMed

Publication types

MeSH terms